Compound ID | 2799
Class: Membrane-active agent
| Agent Type: | Synthetic; Direct acting; |
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Membrane-active agent. Nitric oxide is a cell-membrane active agent (lipid peroxidation), additionally induces oxidative and nitrosative stress (by reactive nitrogen species) |
| Target Pathogen: | Active against non-tuberculous mycobacteria: Mycobacterium abscessus, Mycobacterium avium, Mycobacterium chimaera , Mycobacterium intracellulare |
| Propensity to select resistant mutants: | No |
| Description: | Synthetic compound; provides a sustained release of nitric oxide at physiological conditions; 2.5-3.1 CFU/ml log reduction in Mycobacterium abscessus infection in macrophages |
| Institute where first reported: | Vast Therapeutics, Durham, North Carolina, USA |
| Year first mentioned: | 2024 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://journals.asm.org/doi/10.1128/aac.01327-23 |